Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
63957.14%
operating margin TTM
-170335.71%
revenue TTM
280.44 Thousand
revenue per share TTM
0.11$
valuation ratios | |
|---|---|
| pe ratio | 12.09 |
| peg ratio | 0.31 |
| price to book ratio | 63.66 |
| price to sales ratio | 1,982.74 |
| enterprise value multiple | -2.20 |
| price fair value | 63.66 |
profitability ratios | |
|---|---|
| gross profit margin | -285.71% |
| operating profit margin | -170335.71% |
| pretax profit margin | 63885.71% |
| net profit margin | 63957.14% |
| return on assets | 133.03% |
| return on equity | -128.47% |
| return on capital employed | -544.58% |
liquidity ratio | |
|---|---|
| current ratio | 2.45 |
| quick ratio | 2.45 |
| cash ratio | 1.81 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 6,471.94 |
| cash conversion cycle | -6,471.94 |
| receivables turnover | 0.00 |
| payables turnover | 0.06 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.03 |
| debt equity ratio | 0.13 |
| long term debt to capitalization | 0.12 |
| total debt to capitalization | 0.12 |
| interest coverage | 6.41 |
| cash flow to debt ratio | -109.63 |
cash flow ratios | |
|---|---|
| free cash flow per share | -2.55 |
| cash per share | 0.44 |
| operating cash flow per share | -2.55 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -109.63 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -1,131.14 |
Frequently Asked Questions
When was the last time AgeX Therapeutics, Inc. (AMEX:AGE) reported earnings?
AgeX Therapeutics, Inc. (AGE) published its most recent earnings results on 31-03-2025.
What is AgeX Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. AgeX Therapeutics, Inc. (AMEX:AGE)'s trailing twelve months ROE is -128.47%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. AgeX Therapeutics, Inc. (AGE) currently has a ROA of 133.03%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did AGE's net profit margin stand at?
AGE reported a profit margin of 63957.14% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is AGE's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.45 in the most recent quarter. The quick ratio stood at 2.45, with a Debt/Eq ratio of 0.13.